Cases & Deals

Pfizer acquires Angiosyn, a biopharmaceutical company

Clients Pfizer, Inc.

Jones Day acted as principal outside tax counsel to Pfizer in its agreed acquisition of Angiosyn, a biopharmaceutical company focused on the discovery and development of technology to ward off blindness.